- Home
- NVO vs MRVL Comparison
NVO vs MRVL Comparison
Compare NVO & MRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | MRVL |
|---|---|---|
| Founded | 1923 | 1995 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.4B | 235.4B |
| IPO Year | 2001 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NVO | MRVL |
|---|---|---|
| Price | $40.25 | $139.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 44 |
| Target Price | $45.11 | ★ $311.29 |
| AVG Volume (30 Days) | 8.7M | ★ 19.9M |
| Earning Date | 11-04-2026 | 12-01-2026 |
| Dividend Yield | ★ 3.18% | 0.18% |
| EPS Growth | N/A | ★ 400.98 |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $8,194,600,000.00 |
| Revenue This Year | N/A | $47.30 |
| Revenue Next Year | $1.30 | $63.70 |
| P/E Ratio | ★ $13.60 | $419.47 |
| Revenue Growth | N/A | ★ 42.09 |
| 52 Week Low | $35.12 | $70.69 |
| 52 Week High | $64.16 | $329.88 |
Technical Indicators
Market Signals| Indicator | NVO | MRVL |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 24.16 |
| Support Level | $37.99 | $78.85 |
| Resistance Level | $41.41 | $170.84 |
| Average True Range (ATR) | 0.68 | 13.60 |
| MACD | 0.36 | -11.01 |
| Stochastic Oscillator | 46.50 | 3.08 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.